Seegene HOME > Product > Seeplex® > MRSA ACE Detection
Drug Resistance Detection
Detection of MRSA
(methicillin resistant Staphylococcus aureus)
Seeplex® MRSA ACE Detection simultaneously
detects mecA causing methicillin resistance and
Staphylococcus aureus-specific gene (nuc).
NOT AVAILABLE IN THE US
Seeplex® MRSA ACE Detection is multiplex PCR method based on DPO™ technology which can provide high specificity and sensitivity. It offers faster turnaround time than culture method to diagnose most prevalent hospital acquired infection of methicillin resistance Staphylococcus aureus (MRSA).
A. Multiplex PCR with high sensitivity and specificity by applying DPO™ (Dual Priming Oligonucleotide) technology
  DPO™ based primers contain two priming parts so that only target gene is specifically amplified.
B. Applicable for Auto-capillary Electrophoresis device
  PCR amplicons are separated and analyzed automatically; consequently, rapid and easy interpretation of the results is made possible.
 
C. Contamination Prevention System
  One-time PCR reduces the carryover contamination risk, and 8-MOP, which is included in each set of products, eliminates the contamination risk from PCR.
D. Accurate system for interpretation of results
  Internal Control and Positive Control are included in each set of products.
- mecA
- Staphylococcus aureus-specific gene (nuc)
- Selective liquid or solid medium inoculated with nasal swab or skin
ScreenTape®
System
(Agilent
Technologies)

MCE®-202
MultiNA
SHIMADZU
Product Cat. No. Size
Seeplex® MRSA ACE Detection
MR6200Y 50 rxns
SEARCH
side 배너 제품부분
Simultaneous detection of 16 viruses using...
Obtained CE-IVD marking for Anyplex™ Flu...
Launched Anyplex™ TV/MH Real-time Detect...
Detection of T. vaginalis and M. hominis